about
A 3-year randomized therapeutic trial of nitisinone in alkaptonuriaReversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report.Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1.Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.Experience of a Single Center in NTBC Use in Management of Hereditary Tyrosinemia Type I in LibyaOld treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool.Corneal depositions in tyrosinaemia type I during treatment with Nitisinone.Triketone toxicity: a report on two cases of sulcotrione poisoning.Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.
P2860
Q24624747-3C131B5E-887C-469B-B29F-8AFE8690EEBCQ34560227-DDA20B70-4C93-409A-A77A-5354285DBFE9Q34590786-3C78BADF-A1CD-4F23-BAD1-D9B2FBF1E055Q35141048-4E275943-F73B-4539-9C7F-44CC6FD70E03Q36175625-4F48E0DC-519D-40AA-94E0-A4CE8C17AC44Q38414587-B557CA4D-0C22-42EB-8A24-C1D1BBA9A284Q39024172-7AEB101F-E1CD-4418-B45B-20D1C11F7D98Q41878517-444A5265-D79D-46E0-91E8-188DE674AB94Q44529698-496B9E18-16F3-4A20-BC11-8676CCA7A35BQ47137137-5AE187F3-1B4F-488D-A647-AFFD164CBF7EQ50850348-24CA6B15-38DB-4303-BE95-30E63DF8808E
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Corneal opacities associated with NTBC treatment.
@en
Corneal opacities associated with NTBC treatment.
@nl
type
label
Corneal opacities associated with NTBC treatment.
@en
Corneal opacities associated with NTBC treatment.
@nl
prefLabel
Corneal opacities associated with NTBC treatment.
@en
Corneal opacities associated with NTBC treatment.
@nl
P1476
Corneal opacities associated with NTBC treatment
@en
P2093
Gregg T Lueder
Saad Ahmad
P304
P356
10.1016/S0002-9394(02)01532-5
P407
P577
2002-08-01T00:00:00Z